Biologics, engineered for better control

At TROYA, we use protein engineering to control the activity of medicines, improving their potency and safety.

Our biotherapeutics platform is based on a novel, natural scaffold that activates medicines at the disease site, resulting in precise therapeutic action.

Contact us

Austin W. Boesch, PhD

Christoffer K. Goth, PhD

Seandean L. Harwood, PhD

Viktor T. Lemgart, PhD

Ulrik B. Nielsen, PhD